Pharmaron Beijing Co Ltd (SZSE:300759) Share Price

Company Profile

Business description
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Contact
6 Tai-He Road
8th Floor, Block 1
Beijing Economic Technological Development Area
Beijing100176
CHN
T: +86 1057330087
https://www.pharmaron.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
22,908

Recommended

The ASX, known for its yield appeal is at its lowest level in 20 years. Here’s why, and what investors should do.

Steve Lambeth | 02 February 2026

We’ve raised our fair value estimate of Exxon stock.

Allen Good, CFA | 02 February 2026

Growth in areas critical to the firm’s future.

Matthew Dolgin, CFA | 02 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,149.30	6.90	-0.08%
CAC 40	8,200.38	19.21	0.23%
DAX 40	24,927.67	130.15	0.52%
Dow JONES (US)	49,407.66	515.19	1.05%
FTSE 100	10,334.87	6.69	-0.06%
HKSE	26,834.77	59.20	0.22%
NASDAQ	23,592.11	130.29	0.56%
Nikkei 225	54,720.66	2,065.48	3.92%
NZX 50 Index	13,421.52	9.08	0.07%
S&P 500	6,976.44	37.41	0.54%
S&P/ASX 200	8,857.10	9.20	-0.10%
SSE Composite Index	4,067.74	51.99	1.29%